
Check out Investor Copilot custom GPT, which lets you enjoy ChatGPT functionality with recent financial information
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Historical Deciles for [FOLD] Amicus Therapeutics Inc
Data updated 2022-May-03 (Tuesday)Compare current performance/technical metrics to history for Amicus Therapeutics Inc. Range of values presented below in deciles puts current values into historical context (Up to 5-years)
Provided As-is for informational/educational purposes only and should not be construed as investment advice . Past performance may not be not indicative of future results. Always consult your Investment Adviser before any decision
Share
Use widget to view Historical Metric Deciles for other Stocks/ETFs/Indices
Summary 2022-May-03 Tuesday
Day Change | -0.43% Mid | Day Volatility | 3.19% Mid |
Streak | ↓ 3 days Low | % Streak | -4.77% Low |
RSI | 28 Low | CCI | -126.8 Low |
MACD | -0.11 Low | ATR | 0.4 Mid |
ADX | 36.2 Top | SSO | 9.2 Low |
Change | Volatility | % off SMA | |
---|---|---|---|
5-day | -6.18% Low | 11.00% Mid | -2.05% Low |
10-day | -14.88% Low | 22.73% Top | -6.98% Low |
20-day | -27.89% Low | 43.84% Top | -13.26% Low |
50-day | -21.04% Low | 51.32% Mid | -19.01% Low |
100-day | -37.96% Low | 85.04% Mid | -25.78% Low |
200-day | -25.82% Low | 85.04% Mid | -30.80% Low |
Choose Metric type
Select Performance timeframe above to analyze
On 2022-May-03, Amicus Therapeutics Inc had:daily change of -0.43% intraday volatility of 3.2% 3 ↓ (down) day streak yielding -4.77% See how this compares to historical ranges below. Upto last 5 years are bucketed into deciles (click on chart line for details) with 2022-May-03 value annotated for comparison
Related to Amicus Therapeutics Inc
Information for Amicus Therapeutics Inc
Current Detail : Recent daily/monthly performance & benchmark comparison
Historical Detail : Historical performance & related information using Time Machine
Financial Statements : Analyze Income Statement, Balance Sheet & Cashflow Statement and also compare with peers
Bayesian Statement Classifier : Investigate historical financial statements to make probabalistic predictions using Artificial Intelligence
Anomaly Detection : Investigate unusual recent performance & technicals with historical context using AI
Historical Seasonality : Seasonal performance by calendar months
Technical History : Popular Technical indicator trends (RSI, MACD etc.)
Metric Deciles : Contextualizing recent performance & technical levels into historical decile buckets Currently Viewing
Dollar Cost Averaging : Dollar Cost Average (DCA) over time in your portfolio
Moving Averages : Key Simple & Exponential Moving Averages
Historical Analogues : Insights from closest historical matches to recent performance using Artificial Intelligence
Chart Pattern Matching : Insights from similar historical charts to recent chart using Artificial Intelligence
News Stories : News stories on 2025-May-27 on Google
SEC Reports : Quarterly reports around 2025-May-27 on SEC Edgar
Compare Amicus Therapeutics Inc with other assets
Market Performance : Recent performance across covered assets
Historical Performance : Prior & Subsequent performance across assets on a historical date
Market Technicals : Technical indicator levels across covered assets
Market Seasonality : Seasonal performance by calendar months across covered assets
Pair Correlations : Performance Correlations with other assets
Beta : Volatility relative to the broad market
Performance Comparison : Visually compare/benchmark performance with other assets over time
Side-by-Side Comparison : Contrast with other assets over time in a side-by-side presentation
Sector : Health Care sector performance which includes Amicus Therapeutics Inc
Industry : Biotechnology industry performance which includes Amicus Therapeutics Inc